On February 22, 2023, TINAVI Medical Technologies Co., Ltd. closed the transaction. The company issued 29,545,091 shares at an issue price of CNY 12.53 per share for gross proceeds of CNY 370,199,990.23. The transaction included participation from Caitong Fund Management Co.

Ltd. for 4,349,561 shares, UBS Group AG for 3,431,763 shares, Nuode Asset Management Co., Ltd. for 3,168,395 shares, Jinan Jiangshan Investment Partnership Enterprise (Limited Partnership) for 159,623 shares, Jiangsu Ruihua Investment Management Co., Ltd.—Ruihua Choice No. 8 Private Securities Investment Fund for 4,070,231 shares, Hefei Haiheng International Logistics Co., Ltd. for 3,990,422 shares, JPMorgan Chase Bank, National Association for 2,394,253 shares, Taikang Asset Juxin Stock-Specific Pension Products for 2,394,253 shares, Anhui Bontai Technology Development Co., Ltd. for 1,995,211 shares, along with individual investors, Zhang Zhongxiao for 2,394,253 shares and Cai Xiuqing for 1,197,126 shares. The company incurred CNY 10,443,396.23 as issuance fees.

Through the transaction, the company's share capital has increased from CNY 419,846,848 to CNY 449,391,939.